Surveillance of Neisseria meningitidis in Argentina, 1993-2005: Distribution of serogroups, serotypes and serosubtypes isolated from invasive disease;Vigilancia de Neisseria meningitidis en Argentina, 1993-2005: Distribución de serogrupos, serotipos y serosubtipos causantes de enfermedad invasiva

Revista Argentina de Microbiologia

Volumn 39, Issue 1, 2007, Pages 21-27

  Chiavetta, L ^a   Chavez E ^a   Ruzic, A ^a   Mollerach, M ^b   Regueira, M ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Neisseria meningitidis; Serogroup; Serosubtypes; Serotypes; Surveillance

Indexed keywords

ARGENTINA; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM ISOLATE; HUMAN; INCIDENCE; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; NEISSERIACEAE INFECTION; NONHUMAN; SEROPREVALENCE; SEROTYPING;

ARGENTINA; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS;

EID: 34248212891     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Abdillahi H, Poolman JT. Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987; 48: 367-71.
2. Aguilera JF, Perrocheau A, Meffre C, Hahné S. Outbreak of serigroup W135 meningococcal disease after the Hajj Pilgrimage, Europe, 2000. Emerg Infect Dis 2002; 8: 761-7.
3. Ala' Aldeen DAA, Neal DA, Ait-Tahar K, Nguyen-Van-Tam JS, English A, Falla TJ, et al. Dynamics of meningococcal long-term carriage among university students and their implications for mass vaccination. J Clin Microbiol 2000; 38: 2311-6.
4. Alcalá B, Salcedo C, Arreaza L, Berrón S, De La Fuente L, Vázquez JA. The epidemic wave of meningococcal disease in Spain en 1996-1997: probably a consequence of strain displacement. J Med Microbiol 2002; 51: 1102-6.
5. Almeida González LPC, Pérez LF, Santos Preciado JI. Enfermedad por meningococco, Neisseria meningitidis: perspectiva epidemiológica, clínica y preventiva. Salud Pública Mex 2004; 46: 438-50.
6. Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP) Disease. MMWR 2005; 1-21.
7. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4: 359-95.
8. Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997; 16: 979-83.
9. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev 2006; 19: 142-64.
10. Hubert B, Caugant D. Recent Changes in meningococcal disease in Europe. Euro Surveill 1997; 2: 69-71.
11. Jolley KA, Kalmusova J, Feil EJ, Gupta S, Musilek M, Kriz P, et al. Carried meningococci in the Czech Republic: a diverse recombining population. J Clin Microbiol 2000; 38: 4492-8.
12. Koneman EW, Stephen DA, Williams MJ, Schrenberger PC, Washington CW. Diagnóstico Microbiológico. Buenos Aires, Argentina: Editorial Mèdica Panamericana; 1999, p. 481-512.
13. Navarro-Alonso JA. La inmunization activa frente a Neisseria meningitidis serogrupo B. Enferm Infecc Microbiol Clin. 2003; 9:513-9.
14. Neal KR, Nguyen-Van-Tam JS, Jeffrey N, Slack RC, Madeley RJ, Ait-Tahar K, et al. Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectinal study. BMJ 2000; 320: 846-9.
15. O'Hallahan J, Lennon D, Oster P. The strategy to control New Zealand's epidemic of group B meningococcal disease. Pediatr Infect Dis. 2004; 23: S293-8.
16. Pérez O, Lastre M, Lapinet J, Bracho G, Díaz M, Zayas C, et al. Inmune response induction and new effector mechanisms possibly involved in protection conferred by the cuban anti-meningococcal BC vaccine. Infect Immu 2001; 69: 4502-8.
17. Pírez C, Picón T, Galazka J, Rubio I, Montano A, Ferrari AM. Control de un brote epidémico de enfermedad meningocóccica por Neisseria meningitidis serogrupo B. Rev Med Uruguay 2004; 20: 92-101.
18. Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004; 23: S274-9.
19. Rosenstein N, Perkins B, Stephens D, Popovic T, Hughes J. Meningococcal disease. N Engl J Med 2001; 344: 1378-88.
20. Sacchi CT, Pessoa LL, Ramos SR, Milagres LG, Camargo MC, Hidalgo NTR, et al. Ongoing group B Neisseria meningitidis epidemic in Saõ Paulo, Brazil, due to increased prevalence of a single clone of the ET-5 complex. J Clin Microbiol 1992; 30: 1734-8.
21. Sacchi CT, Tondella ML, de Lemos AP, Goda MC, Berto DB, Kumiochi NH, et al. Characterization of epidemie Neisseria meningitidis serogroup C strains in several Brazilian states. J Clin Microbiol 1994; 32: 1783-7.
22. Schwartz B, Moore PS, Broome CV. Global epidemiology of meningococcal disease. Clin Microbiol Rev 1989; 2: S118-24.
23. Stanwell-Smith RE, Stuart JM, Hughes AO, Robinson P, Griffin MB, Cartwright K. Smoking, the environment and meningococcal disease: a case control study. Epidemiol Infect 1994; 112: 315-28.
24. Stuart JM, Cartwright KA, Robinson PM, Noah ND. Effect of smoking on meningococcal carriage. Lancet North Am Ed 1989; 2: 723-5.
25. Takahashi H, Kuroki T, Watanabe Y, Tanaka H, Inouye H, Yamai S, et al. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol 2004; 53: 657-62.
26. Taha M-K. Molecular detection and characterization of Neisseria meningitidis. Expert Rev Mol Diagn 2002; 2: 89-96.
27. Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol 2004; 53: 821-32.